Health Journal Online

Tag: Travelers

  • U.S. Airport Ebola Screening Remains Active Through July 21: What Returning Travelers Need to Know

    U.S. Airport Ebola Screening Remains Active Through July 21: What Returning Travelers Need to Know

    Enhanced Ebola screening is currently active at three major U.S. international airports, and entry restrictions for travelers from the Democratic Republic of the Congo, Uganda, and South Sudan remain in effect through approximately July 21, 2026. The measures were put in place in response to a growing outbreak of Bundibugyo virus disease — a rare and potentially fatal strain of Ebola for which no approved vaccine or specific treatment exists.

    Travelers who have recently returned from those regions, or who plan to travel there, need to understand what these measures require and what symptoms demand immediate medical attention.

    Why This Matters

    The Bundibugyo strain of Ebola is not the same as the Zaire strain responsible for West Africa’s 2014–2016 epidemic. The FDA-approved Ebola vaccine that provided protection in those prior outbreaks is not considered effective against the Bundibugyo virus. There are no approved countermeasures specific to this strain, which means containment relies on surveillance, contact tracing, isolation, and border screening.

    Case fatality rates for Bundibugyo virus disease in prior outbreaks have ranged from approximately 25% to 50%, according to the CDC — lower than Zaire Ebola but still highly serious. Patients experience fever, vomiting, severe weakness, and in some cases bleeding. Without a vaccine or treatment option, early identification of cases among arriving travelers is critical to preventing domestic spread.

    The World Health Organization has declared this outbreak a Public Health Emergency of International Concern — its highest alert designation.

    What We Know So Far

    The DRC’s Ministry of Health confirmed the Bundibugyo outbreak on May 15, 2026, after laboratory analysis identified Bundibugyo virus in samples from clusters of severe illness and deaths in Ituri Province. The affected health zones — Mongbwalu and Rwampara — are in northeastern DRC near the Ugandan border.

    By mid-June 2026, the DRC had reported 837 confirmed cases and 196 confirmed deaths. Uganda confirmed cases linked to travelers from DRC. South Sudan, which borders both countries, has not confirmed any cases but is included in U.S. entry restrictions due to the geographic risk.

    The U.S. response has been layered:

    As of the most recent CDC update, one American citizen who worked in DRC tested positive for Ebola but has since fully recovered and was released from care. High-risk contacts completed 21-day monitoring without developing symptoms. The CDC assesses the risk to the general U.S. public as low. No cases have been acquired domestically.

    Which Airports Are Conducting Screening

    The CDC and U.S. Customs and Border Protection (CBP) are conducting enhanced Ebola screening at three designated airports for travelers arriving from DRC, Uganda, or South Sudan:

    • Washington Dulles International Airport (IAD) — for flights departing affected countries after May 21, 2026
    • Hartsfield-Jackson Atlanta International Airport (ATL) — for flights after May 22, 2026
    • George Bush Intercontinental Airport, Houston (IAH) — for flights after May 26, 2026

    U.S. citizens and nationals who have been in the affected countries are permitted to return but must enter through one of these designated airports and undergo enhanced public health screening, which may include a health interview, temperature check, and review of symptoms. Travelers without symptoms will receive monitoring instructions and may continue to their final destination.

    According to the U.S. Embassy in DRC, travelers should be prepared for possible flight changes or cancellations when routing through these airports.

    Where the Risk Is Highest

    The active outbreak is concentrated in Ituri Province in northeastern DRC, particularly the Mongbwalu and Rwampara health zones. The CDC notes that the affected areas experience insecurity, population displacement, mining-related movement, and frequent cross-border traffic — all factors that increase transmission risk and complicate outbreak containment.

    In the United States, travelers and healthcare workers who have recently returned from DRC, Uganda, or South Sudan face the primary risk. International humanitarian workers, aid and medical personnel, journalists, researchers, and missionaries are the groups with the highest likelihood of having been in outbreak zones.

    Healthcare facilities in Atlanta, Houston, and the Washington D.C. metropolitan area should maintain heightened awareness given their proximity to the designated screening airports. Emergency departments and infectious disease units in these cities are most likely to encounter a returning traveler who develops symptoms during the 21-day monitoring period.

    What Doctors and Experts Say

    The CDC’s Health Alert Network advisory (HAN 00530) issued May 19, 2026, emphasized that “the risk of spread to the United States is considered low at this time” but called on clinicians to remain vigilant. The agency stated it is working through its country offices and international partners to support disease tracking, contact tracing, laboratory testing, and border health screening.

    The CDC noted a specific challenge with this outbreak: the FDA-approved vaccine (Ervebo) is effective against Zaire ebolavirus — the species responsible for major past outbreaks — but is not considered effective against Bundibugyo virus. The absence of an approved countermeasure for this strain makes infection control and early case detection especially critical.

    WHO Director-General Tedros Adhanom Ghebreyesus, in public statements cited across multiple outlets covering the outbreak’s early weeks, acknowledged that the delay in detecting the initial cluster meant response teams were “playing catch-up with a very fast-moving epidemic.” Contact tracing, treatment center establishment, and infection control measures have been scaled up since.

    For healthcare providers seeing patients who have returned from affected regions, the CDC recommends immediately placing potentially symptomatic patients under appropriate infection control precautions and contacting local or state public health departments for guidance on testing and isolation.

    What the Evidence Shows and What It Does Not

    The Bundibugyo virus has caused only two prior recorded outbreaks — Uganda in 2007 and DRC in 2012 — making it less well-studied than Zaire ebolavirus. Prior outbreaks had case fatality rates of approximately 25% to 50%, but that range reflects small sample sizes and variable outbreak conditions.

    Airport screening can identify travelers who are symptomatic at the time of arrival but cannot detect those who are infected but not yet showing symptoms. As the CDC states: “Public health entry screening cannot identify travelers who are infected but not yet showing symptoms.” The incubation period for Ebola is 2 to 21 days. Screening is therefore one component of a multilayered public health response, not a complete safeguard.

    The 21-day post-departure monitoring requirement for returning travelers exists precisely because of this gap.

    Who Faces the Greatest Risk?

    Based on current epidemiological data and CDC guidance, the highest-risk individuals in the United States are:

    • People who have traveled to or from Ituri Province, DRC, within the past 21 days
    • Humanitarian aid workers, healthcare volunteers, and missionary workers returning from DRC or Uganda
    • People who had direct contact with the blood or bodily fluids of a person confirmed or suspected to have Bundibugyo virus disease
    • Healthcare workers who treated or evaluated patients with suspected BVD without full personal protective equipment
    • Individuals who attended funerals or burial ceremonies in affected areas, where transmission risk is historically elevated

    The CDC’s Level 2 Travel Health Notice recommends avoiding nonessential travel to the specific affected provinces in DRC (Ituri, Nord-Kivu, and Sud-Kivu).

    Symptoms and Warning Signs to Watch For

    Anyone who has been in DRC, Uganda, or South Sudan within the past 21 days should monitor themselves carefully for the following symptoms, which may appear between 2 and 21 days after exposure:

    • Sudden onset of fever (often above 101.5°F / 38.6°C)
    • Severe headache
    • Muscle pain and weakness
    • Fatigue
    • Vomiting and diarrhea
    • Stomach pain
    • Unexplained bleeding or bruising (typically a later sign)

    The development of any of these symptoms in a person who has recently returned from an affected region requires immediate action. Do not travel to a hospital or clinic without calling first. Contact your local health department or call 911 and tell the dispatcher about your recent travel and symptoms so that appropriate isolation procedures can be prepared before you arrive.

    What You Can Do Now

    • If you recently returned from DRC, Uganda, or South Sudan, follow your state or local health department’s monitoring instructions for 21 days after your departure date from those countries.
    • Monitor your temperature daily and record any symptoms during the 21-day window.
    • Avoid international and domestic travel during your monitoring period, per CDC recommendations.
    • If you develop any symptoms, do not go directly to a hospital. Call your local health department and inform them of your travel history before seeking care.
    • Register with the Smart Traveler Enrollment Program (STEP) if you are a U.S. citizen in DRC, Uganda, or South Sudan, so the nearest embassy can provide updates and assistance.
    • Healthcare providers who evaluate a returning traveler with fever or other compatible symptoms should immediately implement infection control measures and notify their state health department and the CDC Emergency Operations Center at 770-488-7100.

    Cost and Access: What Patients Should Know

    If a returning traveler is identified as a potential Ebola case, isolation and evaluation will be coordinated by public health authorities. The CDC maintains a network of federal medical stations and Regional Ebola and Special Pathogen Treatment Centers (RESPTCs) capable of safely managing patients with highly infectious diseases.

    For general travelers concerned about health coverage abroad, the U.S. Department of State recommends purchasing travel insurance that includes medical evacuation coverage before traveling to high-risk regions.

    What Happens Next

    The current U.S. entry restriction order expires around July 21, 2026, but may be extended if the outbreak continues to grow. The CDC will assess the epidemiological situation and issue updates as warranted.

    WHO and international partners are working to scale up outbreak response in DRC and Uganda, including contact tracing, treatment access, and community engagement in affected areas. Given that no approved vaccine or specific treatment exists for Bundibugyo virus, containment measures remain the primary line of defense.

    MedicalDaily will follow CDC updates and the WHO outbreak situation report as they are published.

    The Bottom Line

    Ebola airport screening is active at Dulles, Atlanta, and Houston through at least July 21, 2026. The Bundibugyo strain currently affecting DRC and Uganda has no approved vaccine or treatment, and the outbreak has now surpassed 800 confirmed cases with nearly 200 deaths. The CDC assesses the risk to the general U.S. public as low.

    But low risk does not mean no risk. Travelers who have been in affected regions must monitor themselves for symptoms for 21 full days after departure and must contact health authorities — not walk into an emergency room — if symptoms develop. Following official CDC and state health department guidance is the single most important step returning travelers can take.

    Source link

  • Chikungunya Outbreaks Are Now Active in Three Different Countries and Territories Simultaneously — and Summer Travelers Are at Risk from the Caribbean to the Indian Ocean

    Chikungunya Outbreaks Are Now Active in Three Different Countries and Territories Simultaneously — and Summer Travelers Are at Risk from the Caribbean to the Indian Ocean

    Summer 2026 has produced an unusual public health picture on the CDC Travel Health Notices page: three simultaneous active travel notices for chikungunya — the mosquito-borne virus known for causing weeks of debilitating joint pain — across three different geographic regions. Suriname, a country on the northeastern coast of South America, has had an active chikungunya outbreak since February 2026. Mayotte, a French territory in the Indian Ocean off the coast of Mozambique, has been under a CDC chikungunya notice since March 10, 2026. And French Guiana, the French overseas territory on the northern coast of South America adjacent to Brazil, received a new CDC travel notice for chikungunya on June 4, 2026 — just 10 days ago.

    Three simultaneous active outbreaks across two continents and the Indian Ocean, all in destinations that receive American travelers during peak summer season, all involving the same virus, and all preventable by a vaccine that most American travelers have never heard of.

    Chikungunya is caused by the chikungunya alphavirus, transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes — the same species responsible for dengue fever and Zika virus transmission. It cannot spread person to person. It requires a mosquito bite for transmission, which means travelers who effectively prevent mosquito bites can protect themselves. But unlike dengue — for which no reliably effective, widely available vaccine existed in the U.S. until recently — chikungunya now has an FDA-approved single-dose vaccine that provides broad, durable protection.

    The Pattern of These Three Simultaneous Outbreaks

    The geographic distribution of the three current CDC chikungunya notices reflects distinct but parallel epidemiological situations. In Suriname, chikungunya has been circulating since at least February 2026, consistent with the country’s tropical climate that supports year-round Aedes mosquito activity. Suriname borders Guyana to the west, Brazil to the south, and French Guiana to the east — meaning outbreak activity in Suriname creates risk for cross-border spread to adjacent territories, and the French Guiana notice issued June 4 is likely connected to regional transmission dynamics that began in Suriname and Brazil.

    Mayotte’s chikungunya outbreak is separate in origin — the island’s subtropical Indian Ocean climate creates independent conditions for Aedes activity, and chikungunya has a well-documented history of large outbreak cycles in Indian Ocean territories, including the catastrophic 2005–2006 outbreak in La Réunion that infected nearly one-third of the island’s population.

    What these three outbreaks share is the presence of Aedes aegypti or Aedes albopictus at epidemic transmission levels, a population of susceptible individuals without prior immunity, and the current arrival of the summer travel season, which increases the probability of importation to the United States via returning travelers.

    What Chikungunya Does to the Human Body

    The word chikungunya comes from the Makonde language of Tanzania, meaning “that which bends up” — a reference to the stooped posture that patients adopt in response to severe joint pain. The description is medically accurate and experientially unforgettable. After an incubation period of 2 to 12 days following a mosquito bite, patients develop sudden high fever — often above 103°F — accompanied by polyarthralgia, the simultaneous severe painful inflammation of multiple joints. The hands, wrists, ankles, and feet are most commonly affected, and the pain is frequently described by patients as worse than anything they have experienced. Many cannot walk, dress, or grip a cup.

    The acute phase typically lasts 7 to 10 days. Most patients recover. But approximately 25 to 50 percent of people infected with chikungunya develop chronic post-chikungunya arthritis — persistent joint pain that continues for months to years after the initial infection has resolved. This is the longest-lasting and most debilitating consequence of chikungunya, and it disproportionately affects older adults and those with pre-existing joint disease.

    The Vaccine That Travelers Are Not Getting

    The FDA approved Ixchiq (chikungunya vaccine) in November 2023 for adults 18 and older at increased risk of chikungunya exposure. Ixchiq is a live-attenuated, single-dose vaccine that requires no booster and has demonstrated strong immunogenicity and an acceptable safety profile in clinical trials. It is available through travel medicine clinics and many primary care providers.

    Despite its approval, Ixchiq remains significantly underutilized among American travelers to chikungunya-endemic and outbreak-affected regions. Awareness of the vaccine’s existence is low among both patients and some general practitioners who do not specialize in travel medicine. Travelers heading to Suriname, French Guiana, Mayotte, or any of the many Caribbean and South American destinations currently experiencing elevated chikungunya activity should specifically ask about Ixchiq at their travel medicine consultation.

    The vaccine requires at least 28 days to induce full protection, so travelers should plan accordingly — those departing within 28 days should be advised to rely on intensive mosquito bite prevention while the vaccine becomes effective, or may not benefit from vaccination for their current trip. As with all mosquito-borne disease prevention, repellent use, protective clothing, air conditioning, and bed nets remain essential complements to vaccination.

    Frequently Asked Questions

    Q: Where are the current chikungunya outbreaks with CDC travel notices?

    A: As of June 2026, active CDC chikungunya travel notices cover Suriname (February 2026), Mayotte, a French Indian Ocean territory (March 10, 2026), and French Guiana (June 4, 2026).

    Q: What are the symptoms of chikungunya?

    A: Sudden high fever and severe polyarthralgia — simultaneous joint pain in multiple joints, especially the hands, wrists, ankles, and feet — beginning 2 to 12 days after a mosquito bite. The pain is frequently described as the worst the patient has ever experienced. Most cases resolve within 7 to 10 days, but 25–50% develop chronic joint pain lasting months to years.

    Q: Is there a vaccine for chikungunya?

    A: Yes. Ixchiq is an FDA-approved single-dose live-attenuated vaccine for adults 18 and older. It was approved November 2023 and is available at travel medicine clinics. It requires approximately 28 days to become fully effective.

    Q: Who should get vaccinated against chikungunya before travel?

    A: Adults 18 and older traveling to areas with active chikungunya transmission who will have outdoor exposure to mosquitoes. This currently includes travelers to Suriname, French Guiana, Mayotte, and other active outbreak areas.

    Q: How is chikungunya different from dengue fever?

    A: Both are transmitted by Aedes mosquitoes and cause fever. Chikungunya is distinguished by the severe arthralgia (joint pain) that dominates its clinical picture and can persist for months to years. Dengue more commonly causes a characteristic rash, severe headache, and potentially hemorrhagic complications.

    Source link

  • CDC Warns Travelers Of Deadly Virus That Has No Approved Vaccines Or Treatment

    CDC Warns Travelers Of Deadly Virus That Has No Approved Vaccines Or Treatment

    The U.S. Centers for Disease Control and Prevention (CDC) has issued a health advisory warning travelers about an Ebola outbreak in Uganda caused by the deadly Sudan virus, which has no approved vaccines or treatments.

    The CDC raised the alert to Level 2, urging travelers to “Practice Enhanced Precautions,” according to a Health Alert Network advisory issued Thursday.

    The current outbreak of Sudan Virus Disease (SVD) has been reported in the Kampala, Mbale, and Wakiso regions of Uganda. Since 2000, the country has already experienced seven outbreaks of the virus.

    The first case of the current outbreak was identified after a male nurse died from the infection on January 29. A second case, identified as the wife of the index patient, has also developed symptoms and tested positive, according to a WHO weekly bulletin issued last week.

    While three of the man’s close contacts have developed symptoms and are in isolation for treatment and testing, a total of 234 contacts have been traced, including 118 linked to medical settings.

    Although there are no direct flights from Uganda to the United States, travelers from or passing through affected areas can enter the U.S. on flights connecting from other countries. Hence the CDC cautions health officials to be on alert and evaluate any patients suspected of having SVD.

    However, the CDC confirmed that “currently, no suspected, probable, or confirmed Ebola cases related to this outbreak have been reported in the United States, or outside of Uganda.”

    An initial investigation suggests the latest outbreak is not linked to the earlier outbreaks and officials suspect a new jump from animals to people.

    “The source of exposure remains unknown, raising concerns about undetected transmission chains or a new zoonotic spillover,” the WHO bulletin stated. Previous outbreaks have shown a case fatality rate ranging from 41% to 70%.

    As part of the “enhanced precautions” to reduce the risk of infection, the CDC recommends people who travel to Uganda avoid contact with sick individuals, their bodily fluids, and items they have touched, including those who have died. They are also advised to refrain from handling wild animals, visiting high-risk areas like caves or healthcare facilities in affected regions, and engaging in burial practices that involve touching the deceased.

    Travelers are asked to watch out for symptoms during the stay and three weeks after returning. Anyone experiencing symptoms is advised to isolate immediately and alert the local healthcare facility. Symptoms include fever, chills, headache, muscle aches, rash, chest pain, sore throat, nausea, vomiting and diarrhea. As the disease progresses, the patients may also develop unexplained bleeding or bruising.

    “Calling ahead before going to a healthcare facility helps the facility prepare for your arrival, including contacting health authorities and taking any precautions needed to protect staff and other patients,” the CDC said.

    Source link

  • Dine & Staycation Hacks for Travelers in Kuala Lumpur

    Dine & Staycation Hacks for Travelers in Kuala Lumpur



    Kuala Lumpur is right on. The capital of Malaysia just ranked highest among Booking.com‘s 2024 Most Booked Cities in Asia, therefore confirming its must-visit status. What if, however, you want a cool escape free from the burden of foreign travel? Now enter the staycation, a great chance to find the hidden jewels and gastronomic scene of your own city.

    Here are some expert tips for the smart visitor looking for an amazing staycation that combines the city’s rich eating scene with the appeal of boutique hotel Kuala Lumpur:

    Accept Boutique Luxury

    Give up the uniform hotel chains and really enjoy the distinctive character of boutique hotel Kuala Lumpur. Often situated in renovated shophouses or colonial structures, these personal spaces provide a unique mix of legacy and modern design.

    Design buffs will find The Row Kuala Lumpur in Bukit Bintang a refuge for a taste of art deco glamor. Each of the 27 rooms in the hotel features locally produced artwork. Savour a free breakfast made with seasonal, fresh foods in the elegant courtyard of the hotel before heading out to investigate the vibrant retail and entertainment scene of the city.

    Housed in the famous former Malayan Railway Administration offices, Banyan Tree Kuala Lumpur provides a sumptuous urban hideaway if you yearn for a peaceful retreat. Relax in their magnificent rooftop infinity pool with a view of the city skyline, then treat yourself to a spa treatment influenced by old Malay wellness customs.

    Live Like a Local

    The gastronomic scene in Kuala Lumpur reflects the rich multicultural legacy of the city by being a rainbow of tastes. Explore the hidden treasures buried in little areas, outside the tourist attractions.

    See Nasi Lemak Warong Daun Pisang in Bangsar for a real taste of Malay food. Local favorite, this simple restaurant is known for its aromatic coconut milk rice presented with a symphony of accompaniments including hard-boiled eggs, sambal, and crispy fried anchovies.

    Need something hip? See VCR Street Kitchen in Bukit Bintang, a hipster foodies paradise. Nestled in a rebuilt shophouse, this unusual venue features a varied range of eateries and cafes with everything from gourmet burgers to handmade ice cream.

    Discover Gastronomic Pleasures Right Within Your Hotel

    Many boutique hotels in Kuala Lumpur have first-rate restaurants that are attractions unto themselves. These little dining areas offer a flawless extension of your opulent staycation experience.

    Nestled in the Golden Triangle, The Stripes Kuala Lumpur offers visitors delicious French-inspired cuisine at Brasserie Enfin. While the lovely French bistro setting gives your staycation a little Parisian flair, the open kitchen of the restaurant lets guests see culinary expertise personally.

    Plan a table at Fuego at The Face Suites for a remarkable fine-dining experience. Perched on the 25th level of the hotel, this award-winning restaurant presents amazing panoramic views of the cityscape together with creative Latin American cuisine created with fresh, seasonal foods.

    Beyond the Plate: Custom Hotel Rewards

    The real pleasure of a boutique hotel staycation is the individualized care and distinctive activities provided beyond only a nice room.

    Renowned for its well-chosen guest experiences, Changkat Bukit Bintang’s little boutique hotel The Scar Mansion is Take part in a batik-painting lesson, pick about traditional Malaysian cocktail techniques, or go on a guided heritage walk in Kuala Lumpur’s old neighborhoods.

    Staying at The Travelodge Bukit Bintang puts you exactly in the center of the activity.  But visit their rooftop infinity pool for breathtaking city views and a cool plunge if you want a quiet moment.

    Designing the Ideal Staycation

    The energetic tapestry of boutique hotels and varied gastronomic scene in Kuala Lumpur provides the ideal playground for a staycation that will be remembered. There’s a special mix just waiting to be found whether your search is for a taste of the hip hotspots, a lavish getaway, or an immersed cultural experience. So, reject the vacation brochures, welcome the local character, and start a wonderful discovery of your own city.

    Source link